Robert A. Salata, MD

Professor, Medicine, International Health, Epidemiology and Biostatistics

Robert A. Salata, MD, is Professor of Medicine, International Health and Epidemiology and Biostatistics at Case Western Reserve University. Dr. Salata received his BA in Pre-professional Studies and Psychology from the University of Notre Dame. He went on to earn his MD from Case Western Reserve University. He is Executive Vice-Chair of the Department of Medicine and Chief of the Division of Infectious Diseases and HIV Medicine.

He is the International Working Group Leader for the Case CFAR. He is Co-PI of the Case/ University Hospitals Case Medical Center (UHCMC) AIDS Clinical Trials Unit (CTU) as well as Liaison Investigator to our international Clinical Research Site of the Case CTU located at the Joint Clinical Research Centre (JCRC) in Kampala, Uganda. Dr. Salata serves on the Executive Committee of the Oral HIV/AIDS Research Alliance (OHARA) of the National Institute of Dental and Craniofacial Research (NIDCR), is a Co-chair of the ACTG SASC Third-line Working Group for Africa, Haiti and Asia, and serves on the protocol teams for ACTG protocols A5207, A5208 and A5221. He is also a member of protocol 5208 Clinical Management Team. He is also site PI for protocol MTN 001 of the Microbicides Trials Network and serves on the protocol teams for MTN 001 and 015. Dr. Salata is the protocol chair for an upcoming OHARA trial evaluating inexpensive antifungals for oral candidiasis in HIV-infected African adults. He is Case PI of a National Institute for Child and Human Health Development (NICHD) contract evaluating the natural history of primary HIV infection in African women. Dr. Salata is the Case PI for a NIAID-awarded Phase 1 Clinical Trials Unit for Therapeutics for Infectious Diseases.

Dr. Salata has clinical interests in general infectious diseases, travel medicine as well as infections in immunocompromised hosts (HIV/AIDS and transplant-associated). His research interests are in clinical trials and the epidemiology of infectious diseases as well as in clinical trials of antiretrovirals including in resource-limited settings, as well as the epidemiology and prevention of HIV in women including the use of topical microbicides.